Preparation and biodistribution of 99m technetium labelled oxidized LDL in man.
Radiolabelled autologous low density lipoprotein (LDL) has previously been used to study in vivo distribution and metabolism of native-LDL. Non-invasive imaging of atherosclerotic lesions using 99mTc-LDL was shown to be feasible in animal models and patients but the clinical utility remains to be assessed. Since recent reports suggest that oxidized LDL may play a major role in the pathogenesis of atherosclerosis, we developed a technique to oxidize autologous LDL and compared the biodistribution of oxidized-LDL with that of native-LDL in man. In addition, we evaluated the uptake in vivo of oxidized- and native-LDL by atherosclerotic plaques. LDL, obtained from human plasma was treated with various combinations of copper ions and H2O2 to induce oxidative modification by increasing the content of lipid peroxidation products and electrophoretic mobility. When LDL (0.3 mg/ml) was incubated with 100 microM Cu2+ and 500 microM H2O2 oxidation occurred rapidly within 1 h, and was labelled with 99mTc efficiently as native LDL. In vivo distribution studies revealed a faster plasma clearance of oxidized-LDL compared to native-LDL, and a higher uptake by the reticuloendothelial system. Tomographic scintigraphy of the neck in patients suffering from transient ischemic attacks, revealed accumulation of radiolabelled LDL preparations in the carotid artery affected by atherosclerotic lesions. We developed a technique to rapidly oxidize LDL using copper and H2O2. Biodistribution data demonstrate that oxidized-LDL is rapidly cleared from circulation, is taken up mostly by organs rich in macrophages, and can be detected at the level of carotid plaques.
Iuliano
L
L
Institute of Clinical Medicine I, University La Sapienza, Rome, Italy.
Signore
A
A
Vallabajosula
S
S
Colavita
A R
AR
Camastra
C
C
Ronga
G
G
Alessandri
C
C
Sbarigia
E
E
Fiorani
P
P
Violi
F
F
D000328:Adult; D001161:Arteriosclerosis / Q000000981:diagnostic imaging* / Q000378:metabolism; D016893:Carotid Stenosis / Q000097:blood / Q000150:complications / Q000000981:diagnostic imaging*; D019327:Copper Sulfate / Q000494:pharmacology; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D002537:Intracranial Arteriosclerosis / Q000097:blood / Q000150:complications / Q000000981:diagnostic imaging*; D002546:Ischemic Attack, Transient / Q000097:blood / Q000000981:diagnostic imaging* / Q000209:etiology; D015227:Lipid Peroxidation / Q000187:drug effects; D008077:Lipoproteins, LDL / Q000187:drug effects / Q000493:pharmacokinetics*; D008264:Macrophages / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D012157:Mononuclear Phagocyte System / Q000378:metabolism; D011877:Radionuclide Imaging; D013667:Technetium / Q000493:pharmacokinetics*; D014018:Tissue Distribution
D008077:Lipoproteins, LDL; C099252:oxidized low density lipoprotein; D013667:Technetium; D006861:Hydrogen Peroxide; D019327:Copper Sulfate